The story of Viagra, and its parent company copyright, presents a complex case study for investors. Originally a blockbuster drug, generating billions in revenue , its exclusivity period created a wave of generic competition , significantly eroding its position . While certain firms may attempt to capitalize on male sexual dysfunction, the present